A Calin1, L G Kennedy, L Edmunds, R Will. 1. Royal National Hospital for Rheumatic Diseases, Upper Borough Walls, Bath, United Kingdom.
Abstract
OBJECTIVE: To define potential differences and the possible contribution of susceptibility or severity genes in familial versus sporadic ankylosing spondylitis (AS). METHODS: Three hundred twenty patients with AS were studied: 160 who had first-degree relatives with AS (familial) and 160 age- and sex-matched controls who had no first-degree relative with the disease (sporadic). Disease expression in the two groups was evaluated using an index of physical, psychological, and social functioning (the Arthritis Impact Measurement Scales [AIMS]) and an assessment of spinal mobility. RESULTS: Familial disease was significantly milder than sporadic disease as assessed by all measures, e.g., spinal mobility score (mean 4.08 versus 4.65, P < 0.038), AIMS overall impact score (mean 2.63 versus 3.59, P = 0.002), AIMS physical activity score (4.19 versus 5.10 [P = 0.004]), AIMS social function score (4.02 versus 4.60, P = 0.023), and AIMS pain score (4.15 versus 5.33, P = 0.002). CONCLUSION: The greater prevalence of AS in at-risk families may be explained by the occurrence of more AS "susceptibility" genes in those families, whereas the more severe disease, seen in patients with sporadic AS, is conferred by the presence of more "severity" genes than "susceptibility" genes.
OBJECTIVE: To define potential differences and the possible contribution of susceptibility or severity genes in familial versus sporadic ankylosing spondylitis (AS). METHODS: Three hundred twenty patients with AS were studied: 160 who had first-degree relatives with AS (familial) and 160 age- and sex-matched controls who had no first-degree relative with the disease (sporadic). Disease expression in the two groups was evaluated using an index of physical, psychological, and social functioning (the Arthritis Impact Measurement Scales [AIMS]) and an assessment of spinal mobility. RESULTS:Familial disease was significantly milder than sporadic disease as assessed by all measures, e.g., spinal mobility score (mean 4.08 versus 4.65, P < 0.038), AIMS overall impact score (mean 2.63 versus 3.59, P = 0.002), AIMS physical activity score (4.19 versus 5.10 [P = 0.004]), AIMS social function score (4.02 versus 4.60, P = 0.023), and AIMS pain score (4.15 versus 5.33, P = 0.002). CONCLUSION: The greater prevalence of AS in at-risk families may be explained by the occurrence of more AS "susceptibility" genes in those families, whereas the more severe disease, seen in patients with sporadic AS, is conferred by the presence of more "severity" genes than "susceptibility" genes.
Authors: Reeti Joshi; John D Reveille; Matthew A Brown; Michael H Weisman; Michael M Ward; Lianne S Gensler; B Paul Wordsworth; David M Evans; Shervin Assassi Journal: Arthritis Care Res (Hoboken) Date: 2012-05 Impact factor: 4.794
Authors: Hing Wo Tsui; Robert D Inman; Andrew D Paterson; John D Reveille; Florence W L Tsui Journal: Arthritis Res Ther Date: 2005-02-25 Impact factor: 5.156
Authors: Hye Won Kim; Hye Rim Choe; Su Bin Lee; Won Ik Chang; Hyun Jun Chae; Jin Young Moon; Jisue Kang; Sungim Lee; Yeong Wook Song; Eun Young Lee Journal: J Korean Med Sci Date: 2014-05-30 Impact factor: 2.153
Authors: Augusta Ortolan; Miranda van Lunteren; Sofia Ramiro; Roberta Ramonda; Robert B M Landewé; Hanne Dagfinrud; Lennart T H Jacobsson; Désirée van der Heijde; Floris A van Gaalen Journal: Arthritis Res Ther Date: 2018-10-01 Impact factor: 5.156